Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands – study protocol

Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands – study protocol

Introduction The management of type 1 diabetes (T1DM) has undergone significant advancements with the availability of novel technologies, notably continuous and flash glucose monitoring (CGM and FGM, respectively) and hybrid closed loop (HCL) therapy. The dual hormone fully closed loop (DHFCL) appro...

Full description

Bibliographic Details
Main Authors: Frank J Snoek, Karel G M Moons, Mirjam M Oosterwerff, Thomas van Bemmel, Catherine B Brouwer, Arianne C van Bon, Harold W de Valk, J Hans deVries, Lioe-Ting Dijkhorst-Oei, Peter R van Dijk, Klaas Hoogenberg, Sarah E Siegelaar, Titia M Vriesendorp, Erik H Serné, Geert W J Frederix, Milena Jancev, Heleen Knottnerus, Helga Blauw, Maureen Witkop, Thomas T van Sloten, Frits A W Kemperman, Lars P Klieverik, Elin Seebus
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/8/e074984.full

Internet

https://bmjopen.bmj.com/content/13/8/e074984.full

Similar Items